Salmonella risk Recall of goji berries from Lidl
In dried goji berries of the Italian manufacturer V. Besama S.p.A. (San Gennaro vesuviano) salmonella were found. In Germany, the "Superfood" was sold in stores of the food discounter Lidl. The affected product will now be recalled.
Salmonella in dried goji berries
The food discount store Lidl recalls dried goji berries. In the context of self-examination of the Italian manufacturer V. Besama S.p.A. (San Gennaro vesuviano) salmonella were found. These bacteria can cause diarrhea and other medical conditions.
Affected goods were sold only at Lidl Germany
As the Federal Office for Consumer Protection and Food Safety reports on its portal "Lebensmittelwarnung.de", the recall refers to "Alesto Gojibereren trocken, 100g" with the expiry date 31/10/2017 and the lot numbers / lot identification: L7057001 and L7057002.
According to the information, the product concerned was only sold to Lidl Germany in the federal states of Bavaria, Berlin, Brandenburg, Hamburg, Lower Saxony and Schleswig-Holstein.
According to the discounter, the packs can be returned in all stores.
Gastric and intestinal diseases caused by salmonella
Salmonella are bacteria that can cause severe stomach and intestinal disease in humans.
After eating contaminated foods, you may experience discomfort such as abdominal pain, fever, diarrhea, nausea and vomiting.
Especially in infants, people with weakened immune systems and seniors, such symptoms can occur.
Do not combine with blood thinning medication
Goji berries have experienced a veritable boom in recent years. The fruits advertised as "Superfood" contain a lot of minerals like iron, calcium, magnesium as well as the vitamins A, C and E..
For some people, however, the berries can be dangerous. And for those who take certain medications.
Goji berries should not be combined with blood thinners, health experts warn.
The small red fruits have long been suspected to block the breakdown of blood-thinning agents such as phenprocoumone and warfarin. According to the Federal Institute for Drugs and Medical Devices (BfArM), this could lead to bleeding in patients. (Ad)